These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37815836)

  • 21. Risk Factors for De Novo Malignancy Following Lung Transplantation.
    Magruder JT; Crawford TC; Grimm JC; Kim B; Shah AS; Bush EL; Higgins RS; Merlo CA
    Am J Transplant; 2017 Jan; 17(1):227-238. PubMed ID: 27321167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low Incidence of Malignancy After Heart Transplantation in Taiwan.
    Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
    Transplant Proc; 2016 Apr; 48(3):974-7. PubMed ID: 27234782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with skin cancer in lung transplant recipients: A single-center experience.
    Elnahas S; Olson MT; Kang P; Panchanathan R; Masuda T; Walia R; Zeitouni NC; Smith MA; Bremner RM
    Clin Transplant; 2019 Dec; 33(12):e13718. PubMed ID: 31545540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National survey of de novo malignancy after solid organ transplantation in Japan.
    Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
    Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignancy With Immunosuppression After Renal Transplantation: A Competing Risk Analysis.
    Yoshida T; Matsumura S; Imanaka T; Taniguchi A; Yamanaka K; Kishikawa H; Nishimura K
    Transplant Proc; 2020; 52(6):1775-1777. PubMed ID: 32299709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the oncological risk in heart transplant recipients: could skin tumors represent a marker of increased risk for solid neoplasm?
    Guglielmo A; Potena L; Russo A; Masetti M; Prestinenzi P; Giovannini L; Vaccari S; Piraccini BM; Pileri A
    Ital J Dermatol Venerol; 2023 Oct; 158(5):395-400. PubMed ID: 37916399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of de novo malignancy and all-cause mortality among heart transplant recipients.
    Barrera FJ; Mostofsky E; Salia S; Lehman L; Liou L; Mucci L; Mittleman MA
    Int J Cardiol; 2024 Nov; 415():132455. PubMed ID: 39153512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
    Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
    Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors for skin cancer following lung transplantation.
    Rashtak S; Dierkhising RA; Kremers WK; Peters SG; Cassivi SD; Otley CC
    J Am Acad Dermatol; 2015 Jan; 72(1):92-8. PubMed ID: 25440431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De Novo Malignancies After Liver Transplantation: Experience of a High-Volume Center.
    Saglam K; Sahin TT; Ogut Z; Ince V; Usta S; Yilmaz S
    J Gastrointest Cancer; 2022 Dec; 53(4):1020-1027. PubMed ID: 34778909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between infectious event and de novo malignancy after heart transplantation.
    Bujo C; Amiya E; Hatano M; Tsuji M; Maki H; Ishida J; Ishii S; Narita K; Endo M; Ando M; Shimada S; Kinoshita O; Ono M; Komuro I
    Heart Vessels; 2021 Apr; 36(4):499-508. PubMed ID: 33140148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin cancer in heart transplant recipients.
    España A; Redondo P; Fernández AL; Zabala M; Herreros J; Llorens R; Quintanilla E
    J Am Acad Dermatol; 1995 Mar; 32(3):458-65. PubMed ID: 7868716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
    Bhat M; Mara K; Dierkhising R; Watt KDS
    Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.
    O'Neill JO; Edwards LB; Taylor DO
    J Heart Lung Transplant; 2006 Oct; 25(10):1186-91. PubMed ID: 17045930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significantly higher incidence of skin cancer than other malignancies in patients after heart transplantation. A retrospective cohort study in the Czech Republic.
    Secnikova Z; Gopfertova D; Hoskova L; Hercogova J; Dzambova M; Jirakova A; Rajska L; Rob F; Smerhovsky Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):648-51. PubMed ID: 25820624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression.
    Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
    Transplant Proc; 2016 Apr; 48(3):969-73. PubMed ID: 27234781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival.
    Haglund NA; Feurer ID; Ahmad RM; DiSalvo TG; Lenihan DJ; Keebler ME; Schlendorf KH; Stulak JM; Wigger MA; Maltais S
    J Heart Lung Transplant; 2014 Sep; 33(9):931-6. PubMed ID: 24925183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of Malignancies in Patients Treated With Sirolimus Following Heart Transplantation.
    Asleh R; Clavell AL; Pereira NL; Smith B; Briasoulis A; Alnsasra H; Kremers WK; Habermann TM; Otley CC; Li X; Edwards BS; Stulak JM; Daly RC; Kushwaha SS
    J Am Coll Cardiol; 2019 Jun; 73(21):2676-2688. PubMed ID: 31146812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.